IPO Announced

ADARx Pharmaceuticals IPO

US$446m raised

Lodged 24 Sep 2026 · NASDAQ: ADRX · US$17.00 cash per share

Advisers

ADARx Pharmaceuticals

Issuer

Legal adviser
Issuer
ADARx Pharmaceuticals
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.